Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants.
On 31 January 2022, the Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application.
A transition period applies to clinical trial submission under the Regulation.
Table of Contents
3. How to report a serious breach
4. Clarification on reporting requirements
5. Reporting serious breaches – Points to consider
6. Responsibilities of parties involved in the notification of a serious breach
7. General considerations for serious breaches
8. Possible actions taken by the EU/EEA Member States concerned (MSC)
Appendix I – Examples of serious breaches
Appendix II – Points to consider for sponsors in relation to the assessment of a breach
Appendix III a – Template form for reporting serious breaches
Appendix III b – Information to be submitted with a notification of a serious breach
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Próximos ensayos clínicos
-
NCT05884099Aún no reclutandoDolor crónico Cáncer de pulmón Cirugía Efecto de crioterapia
-
NCT05883969Reclutamiento
-
NCT05883670ReclutamientoCáncer de cuello uterino
-
NCT05883644Aún no reclutandoCarcinoma hepatocelular avanzado
-
NCT05884281Aún no reclutandoNeuropatía periférica
-
NCT05884970ReclutamientoAsma en niños Agentes Anti Asmáticos
-
NCT05885113Aún no reclutandoDesarrollo Infantil Retraso en el desarrollo Cardiología
-
NCT05884476Aún no reclutandoIdeación suicida Suicidio, Intento
-
NCT05884580Aún no reclutandoSíntomas del tracto urinario inferior Hiperplasia prostática benigna
-
NCT05883774Aún no reclutandoTrastorno de ansiedad generalizada
-
NCT05885074Aún no reclutandoObesidad Pérdida de peso
-
NCT05884840Aún no reclutandoArteriosclerosis Enfermedad Arterial Periférica Prevención cardiovascular Poner en pantalla Asintomático
Clinical Research Jobs
-
Clinical Trial Coordinator
-
Trial Patient Payment Associate II
-
Senior/Principal Biostatistician
-
Biometrics Project Manager / Delivery Lead
-
Senior Director, Biostatistics - APAC region
-
Senior Health Economics Consultant
-
Clinical Vendor Contracts Analyst - FSP
-
Clinical Contracts Analyst II
-
Senior Contracts Specialist
-
Lab Data Specialist I
-
Associate Manager, Study Start Up (FSP)
-
Financial Analyst II